@Drbader3 The recommended dose is actually 0.25 mg/kg @Cochrane_IDG @LSTMnews 15 mg total for an average adult, and it's only partially effective. We don't know if this will impact transmission though. See: @wiley https://t.co/WtafmJbITq
RT @Cochrane_IDG: Updated @Cochrane_IDG #Cochrane Review on single low dose #primaquine published @GlobalFund @APLMA_Malaria @BillGates @Ga…
Updated @Cochrane_IDG #Cochrane Review on single low dose #primaquine published @GlobalFund @APLMA_Malaria @BillGates @GatesFoundation @ALMA_2030 @MEIatUCSF @FightingMalaria @PATH @macepa_tweets @MESAmalaria @APMEN https://t.co/yQ7rib5fmw
A single low dose of #PQ added to an #artemisinin regimen for #malaria reduces infectiousness to mosquitoes and is relatively safe for most people. Read the latest review update: https://t.co/sACrRrLSGI https://t.co/5itC1tBjHX
What is the aim of this review? https://t.co/Vz4rcnOtb2
Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission. https://t.co/9zIpJnYMFM
Updated #Cochrane Review on single low dose #primaquine just published @jcu @ @AITropHealthMed @CochraneLibrary https://t.co/CpRjaHgyeP … https://t.co/CpRjaHgyeP
Updated #Cochrane Review on single low dose #primaquine just published @jcu @aithm @CochraneLibrary https://t.co/CpRjaHgyeP
RT @PaulGarnerWoof: Mini-primaquine reduces people infecting mosquitoes and malaria transmission? Yes, but effects partial and modest. See…
RT @Cochrane_IDG: Mini-#primaquine reduces people infecting #mosquitoes and #malaria transmission? Yes, but effects partial and modest. See…
RT @Cochrane_IDG: Mini-#primaquine reduces people infecting #mosquitoes and #malaria transmission? Yes, but effects partial and modest. See…
Mini-#primaquine reduces people infecting #mosquitoes and #malaria transmission? Yes, but effects partial and modest. See updated #Cochrane Review from @Cochrane_IDG @PaulGarnerWoof @epivec @mrlesliechoi https://t.co/lzD8CYxAtK
Mini-primaquine reduces people infecting mosquitoes and malaria transmission? Yes, but effects partial and modest. See Cochrane February 2018 Update https://t.co/qKME5CyYHc